FDA Approved: PIOGLITAZONE AND GLIMEPIRIDE — Original Application (Prasco Laboratories)

View source ↗

Summary

FDA approved Pioglitazone and Glimepiride as an original application by Prasco Laboratories. The product is indicated for type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Pioglitazone and Glimepiride (pioglitazone and glimepiride)

Snippet

ORIG AP for PIOGLITAZONE AND GLIMEPIRIDE (PIOGLITAZONE AND GLIMEPIRIDE)